This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: The Innovations of Hans-Dietrich Horlein
Introduction
Hans-Dietrich Horlein is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of proteins that have therapeutic applications. His work has been recognized for its potential impact on human health.
Latest Patents
Horlein holds a patent for hIL-4 mutant proteins, which are utilized as antagonists or partial agonists of human interleukin-4. This innovation represents a crucial advancement in the understanding and treatment of various diseases.
Career Highlights
Throughout his career, Horlein has been associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His role at Bayer has allowed him to work on groundbreaking research and development projects that aim to improve health outcomes.
Collaborations
He has collaborated with esteemed colleagues, including Hanno Wild and Rudolf H. Hanko, to further enhance the scope and impact of his research. These partnerships have fostered a collaborative environment that encourages innovation and discovery.
Conclusion
Hans-Dietrich Horlein's contributions to biotechnology and his innovative patent on hIL-4 mutant proteins highlight his role as a significant figure in the field. His work continues to inspire advancements in medical research and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile